Accelerated patent review pilot

Full Title:
Leadership in CET Act

Summary#

This bill creates a pilot program at the U.S. Patent and Trademark Office (PTO) to speed up patent examination for certain inventions in critical and emerging technologies. The main change is a temporary program that lets eligible patent applications move ahead of others for faster review. The stated goal is to encourage U.S. innovation and leadership in those technologies.

  • Eligible areas: specified kinds of artificial intelligence, semiconductor design and electronic design automation tools, and several quantum science capabilities.
  • Who can apply: noncontinuing, nonprovisional utility patent applications that do not claim earlier domestic priority and whose applicants are not “foreign entities of concern.”
  • How it works: the Director of the PTO will accept covered applications into the pilot and may advance them out of turn by using a petition to make special. The Director can set conditions and may waive certain fees or other accelerated‑review requirements.
  • Limits: the pilot ends after 5 years or after accepting 15,000 covered applications (whichever comes first). The Director may renew once under similar limits.
  • Transparency and review: the PTO must publish basic counts about applications and issue a report to Congress within 180 days after the pilot ends assessing its impact.

What it means for you#

  • Inventors and companies working in AI, semiconductors, or quantum tech: You could get faster patent review if your invention fits the listed technology areas and you meet the eligibility rules. Faster review could mean earlier patent issuance, if the application is allowed.
  • Foreign entities of concern: The bill bars applicants that are defined as “foreign entities of concern” from qualifying for the pilot. If you are so defined, this pilot would not be available to you.
  • Applicants using priority claims or continuations: The pilot only accepts original, noncontinuing utility applications that do not claim domestic priority. Continuations or applications claiming earlier domestic benefit are not eligible.
  • High‑volume inventors: An inventor named as inventor/joint inventor on more than four other covered applications submitted under the pilot cannot be added beyond that limit; applicants must certify this.
  • Patent Office staff and other agencies: PTO staff will need to process and prioritize these applications. The PTO may consult other federal agencies (for example, defense or intelligence agencies) as it implements the program.
  • Public and Congress: The PTO must publish counts of submitted and accepted covered applications and patents issued from expedited cases. The PTO must also report to Congress after the pilot ends.
  • What is unclear: The bill leaves many implementation details to PTO rulemaking, such as selection criteria, processing timelines, and how the PTO will allocate examiner resources. It does not include a public fiscal estimate in the text provided.

Expenses#

No publicly available information on an official cost estimate is provided with this bill text.

  • The bill allows the Director to waive the petition fee used for expedited processing and other accelerated‑examination requirements. Waiving fees could reduce fee revenue to the PTO.
  • Running the pilot could increase PTO administrative and examiner workload; that may require staffing or reallocation of examiner time. The bill does not specify how those costs will be funded.
  • Consulting with other federal agencies and producing the final report may create additional administrative costs; the bill does not provide budget details.

Proponents' View#

  • The bill states its purpose as encouraging innovation and U.S. leadership in critical and emerging technologies by giving those patent applications prompt consideration.
  • Faster patent examination for key technologies could help inventors commercialize ideas sooner and possibly make U.S. firms more competitive.
  • The pilot is limited in time and size (5 years or 15,000 applications), so supporters may see it as a measured, testable approach rather than a permanent change.
  • Requiring public reporting could allow Congress and the public to judge whether the pilot improved outcomes.

Opponents' View#

  • One concern is that faster processing could reduce examination quality if examiner resources are stretched or timelines are tightened; the bill leaves resource allocation to the PTO.
  • The bill lets the Director waive fees. That could lower PTO fee revenue and shift costs without a clear funding plan.
  • Eligibility limits (no continuations, no domestic priority claims, inventor caps) may exclude many applicants who would otherwise benefit but the bill does not explain why those specific limits were chosen.
  • The selection and acceptance criteria are largely left to future PTO rules. It is unclear how transparent or fair the selection process will be in practice.
  • The pilot excludes “foreign entities of concern,” which may raise questions about how that definition is applied and whether it might affect international collaboration; the bill relies on an existing statutory definition but does not add more detail.